Hematology
The American Society of Hematology (ASH) will provide robust, current educational content on topics including changing treatment paradigms in lymphoma treatment, acute myeloid leukemia, chronic leukemias, iron deficiency and replacement, addressing sickle cell care in children and adults, bleeding and bruising for the pediatric primary care provider, understanding and management of immune thrombocytopenia, thrombophilia evaluation, and myeloproliferative neoplasms.
Virtual sessions
Title
Speakers
CME Credit
Changing Treatment Paradigms in Lymphoma Treatment
Geoffrey Shouse, DO, PhD
Iron Deficiency and Replacement
Nicoletta Machin, DO
Acute Myeloid Leukemia: A Primer on Biology and Signs of the Disease
LaQuita Jones, DO
Chronic Leukemias: The Latest Updates and Myths Dispelled
Bhavana (Tina) Bhatnagar, DO
Pediatric Sickle Cell Care and Updates for the General Physician
Jennifer Tran, DO
Bleeding and Bruising for the Pediatric Primary Care Provider
Andrew Picca, DO, MAEd
Advancements in Understanding and Management of Pediatric and Adult Immune Thrombocytopenia (ITP)
Melissa Rose, DO
Thrombophilia Evaluation
Shanley Banaag, DO
Addressing Sickle Cell Disease Across the Age Spectrum: Current Therapies and Future Directions
Oluwaseun (Kemi) Olaiya, DO
Myeloproliferative Neoplasms
Mark Faber, DO
Changing Treatment Paradigms in Lymphoma Treatment
Learning Objectives
- Describe key changes in the treatment landscape of major non-Hodgkin lymphoma subtypes (DLBCL, CLL, MCL, and FL) over the past five years
- Compare the evolving roles of autologous stem cell transplantation, CAR T-cell therapy, and other cellular therapies in frontline and relapsed/refractory settings
- Evaluate the mechanisms, clinical efficacy, and appropriate use of bispecific antibodies and molecularly targeted therapy combinations across lymphoma subtypes
- Apply current evidence to guide treatment selection and sequencing strategies based on disease characteristics and patient-specific factors
Speakers
Geoffrey Shouse, DO, PhD
Iron Deficiency and Replacement
Learning Objectives
- Explain how anemia and iron deficiency may be underappreciated in women when relying on traditional reference ranges
- Interpret common iron studies with an emphasis on ferritin as a key marker of iron stores
- Compare practical approaches to oral and intravenous iron replacement, including when IV iron should be considered
Speakers
Nicoletta Machin, DO
Acute Myeloid Leukemia: A Primer on Biology and Signs of the Disease
Learning Objectives
- Describe features of the clinical presentation of AML
- Review general information about patient outcomes
- Discuss the treatment landscape for AML
Speakers
LaQuita Jones, DO
Chronic Leukemias: The Latest Updates and Myths Dispelled
Learning Objectives
- Discuss the latest updates on treatment and monitoring paradigms for chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)
- Provide a brief review of ongoing research in the management of CLL and CML
- Review and address common misconceptions regarding CML and CLL patients
Speakers
Bhavana (Tina) Bhatnagar, DO
Pediatric Sickle Cell Care and Updates for the General Physician
Learning Objectives
- Describe the epidemiology of sickle cell disease
- Describe the pathophysiology of sickle cell disease
- Identify and manage acute complications of sickle cell disease in children
- Describe preventative care for children with sickle cell disease
- Discuss curative/transformative options for children with sickle cell disease
Speakers
Jennifer Tran, DO
Bleeding and Bruising for the Pediatric Primary Care Provider
Learning Objectives
- Illicit all portions of history for the ISTH Bleeding Assessment Tool (BAT) and adequately interpret BAT score to aid in clinical decision making
- Associate screening laboratory tests with potential underlying bleeding disorders
- Evaluate and determine if circumcision is appropriate for newborns with a family history of von Willebrand Disease
- Identify one or more clinical indications for the treatment of Immune Thrombocytopenia (ITP)
Speakers
Andrew Picca, DO, MAEd
Advancements in Understanding and Management of Pediatric and Adult Immune Thrombocytopenia (ITP)
Learning Objectives
- Describe the pathophysiology of immune thrombocytopenia
- Summarize the American Society of Hematology (ASH) guidelines for immune thrombocytopenia in pediatric and adult patients
- Review recent clinical trials exploring more novel management
Speakers
Melissa Rose, DO
Thrombophilia Evaluation
Learning Objectives
- Introduce hereditary and acquired thrombophilias
- Discuss indications for thrombophilia evaluation
- Explain which tests to order and how to interpret results
- Describe how thrombophilia testing results can impact anticoagulation
Speakers
Shanley Banaag, DO
Addressing Sickle Cell Disease Across the Age Spectrum: Current Therapies and Future Directions
Learning Objectives
- Describe the clinical presentation of Sickle Cell Disease
- Describe and identify the common complications of Sickle Cell Disease
- Summarize the current therapies for patients with Sickle Cell Disease
- Apply evidenced based management strategies when caring for individuals with Sickle Cell Disease
Speakers
Oluwaseun (Kemi) Olaiya, DO
Myeloproliferative Neoplasms
Learning Objectives
- Properly identify and diagnose Polycythemia Vera
- Describe the treatment of Polycythemia Vera
- Identify and diagnose Essential Thrombocytosis
- Discuss the treatment of Essential Thrombocytosis
- Identify and diagnose Myelofibrosis (primary and secondary)
- Outline the treatment of Myelofibrosis
Speakers
Mark Faber, DO